Executive Summary
Across the 50 SEC filings from the USA Dow Jones 30 intelligence stream (primarily financials, insurers, and related blue-chips, with some small-caps), Q1 2026 earnings dominate, revealing strong YoY net income growth averaging +100% in key financials (Travelers +333%, BNY +42% EPS, US Bancorp +13.8%, BancFirst +12.3%, Bank First +9.9%) driven by lower catastrophe losses, NII expansion (Bank First +45.8% YoY), and fee growth, though QoQ dips (-4.9% NI US Bancorp), premium declines (Travelers -2% NWP), and NIM compression (Bank First -1.2% QoQ) signal moderating momentum. Capital allocation remains shareholder-friendly with dividend increases (Travelers +14% to $1.25, Bank First +22.2% YoY to $0.55) and buybacks ($2.223B Travelers Q1, $1.8B 10-Q). Small-caps show distress patterns: revenue drops (Hooker -20.5% Q4, Vipshop -2.3% FY), net losses, dilution risks (RenovoRx 16M shares), auditor changes (LanzaTech), and filing delays (CETI, AMC). Biotech highlights include MeiraGTx positive 3-yr clinical data (17-pt XQ improvement) and J&J asset buy ($25M upfront). Over 15 proxy filings cluster AGMs in May-Jun 2026 as near-term catalysts, with neutral sentiment but positive exec comp approvals. Portfolio-level: Financials outperform (ROE 19.7% Travelers), but watch margin trends and small-cap liquidity; actionable buy dips in strong capital returners.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from April 09, 2026.
Investment Signals(12)
- Travelers Companies↓(BULLISH)▲
Q1 net income +333% YoY to $1.711B, core income +283% to $1.696B, dividend +14% to $1.25/share, $2.223B shareholder returns incl $1.985B buybacks
- Bank First Corp↓(BULLISH)▲
Q1 NI +9.9% YoY to $20M, NII +45.8% YoY to $53.2M post-$1.48B acquisition (assets +33% to $6.07B), dividend +22.2% YoY to $0.55
- BancFirst Corp↓(BULLISH)▲
Q1 NI +12.3% YoY to $63M, EPS +11.4% to $1.85, NIM expands to 3.74% (+4 bps YoY), noninterest income +5.1% YoY
- U.S. Bancorp(BULLISH)▲
Q1 revenue +4.7% YoY to $7.288B, NI +13.8% YoY to $1.945B, EPS +14.6% to $1.18, ROA +11 bps to 1.15%, efficiency -260 bps to 58.2%
- BNY Mellon(BULLISH)▲
Q1 revenue record +13% YoY/$5.4B, EPS +42% YoY to $2.24, ROTCE 29%, fee revenue +11% YoY despite AUM -2% QoQ
- Faraday Future↓(BULLISH)▲
Amended SPA increases investment to $12M (+20%), eliminates anti-dilution true-up for warrant (1M shares at $1.50 post-500th vehicle), funds EAI robotics targeting 1K deliveries 2026
- Lincoln Educational↓(BULLISH)▲
Amended revolver +108% to $125M (5-yr term to 2031, +$65M liquidity), supports 19-20% Q1 student start growth
- First Business Financial↓(BULLISH)▲
New CEO David Seiler appt (ex-President/COO) with $600K base, $215K RSU grant vesting 5-yrs, signals continuity post-retirement
- MeiraGTx↓(BULLISH)▲
3-yr Phase 1 AQUAx data: 62% patients >=10-pt XQ improvement (avg 17-pt), UWSFR normalizes to 0.34 mL/min, $3.7B peak revenue potential
- Hooker Furnishings↓(BULLISH)▲
FY sales -12.4% to $278.1M but gross margin +180 bps, SG&A -$11.9M, $17.5M fixed cost savings, new $5M buyback + dividend $0.46
- RenovoRx↓(BEARISH)▲
S-3 registers 16M shares resale post-$10M raise, potential +$9.3M from warrants, but highlights dilution/volatility risks
- LanzaTech↓(BEARISH)▲
Auditor dismissal (Deloitte) due to going concern doubts/material weaknesses in revenue/controls, no restatements but ongoing issues
Risk Flags(9)
- Horizon Quantum↓[HIGH RISK]▼
Net loss $17.8M FY25, working capital deficit -$8.2M, delisted NYSE to OTC, going concern doubt/liquidation risk by Mar 29 2026
- LanzaTech/Auditor Change↓[HIGH RISK]▼
Dismissed Deloitte amid FY24/25 going concern doubts, material weaknesses in complex txns/revenue/controls
- Bank First/NPLs↓[MEDIUM RISK]▼
Nonperforming assets double QoQ to $30M (0.50% assets) post-Centre acquisition, NIM -1.2% QoQ to 3.96%, expenses +89% QoQ
- Vipshop Holdings↓[HIGH RISK]▼
FY25 revenue -2.3% YoY to RMB106B (3rd yr decline), NI -5.5% YoY, continuing downtrend from 2023
- Katapult Holdings/Covenants↓[HIGH RISK]▼
10th waiver for Min Net Originations/charge-off breaches since Jun2025, signals persistent liquidity/ops issues
- Hooker Furnishings/Sales↓[MEDIUM RISK]▼
Q4 sales -20.5% YoY to $67M, FY op loss -$16.5M (impaired $15.6M), cash -$5.2M YoY to $1.1M
- SEATech Ventures/No Revenue↓[HIGH RISK]▼
FY25 revenue $0 (flat YoY), cash -96% to $465, assets -46% to $10K, net cash ops -$50K worsening
- Cyber Enviro-Tech/Filing Delay↓[MEDIUM RISK]▼
10-K delay to Apr28+ for fairness opinion on discontinued sub, audit complications
- JOCOM Holdings↓[HIGH RISK]▼
FY25 revenue -100% to $0, net loss $844K vs prior profit, G&A + surge, equity -$106K worsening
Opportunities(8)
- Travelers/Dividend+Buyback↓(OPPORTUNITY)◆
+333% YoY NI, +14% dividend, $5.2B remaining buyback capacity, core ROE 19.7% vs peers, book value $150/share
- BNY Mellon/Record Revenue(OPPORTUNITY)◆
+13% YoY revenue, AUC/A +13% YoY to $42.7T, CET1 11%, potential rebound from QoQ AUM dip
- Bank First/Acquisition Synergies↓(OPPORTUNITY)◆
+33% assets post-$1.48B deal, NII +46% YoY, new branches planned, NIM 3.96%
- MeiraGTx/Clinical Catalyst↓(OPPORTUNITY)◆
3-yr data supports $3.7B peak sales for xerostomia therapy, safe/tolerated, file BLA soon
- MeiraGTx/J&J Asset↓(OPPORTUNITY)◆
Acquired bota-vec for XLRP $25M upfront + royalties, Phase3 secondary endpoints hit (LLQ p<0.01), 2027 launch target
- Faraday Future/Robotics↓(OPPORTUNITY)◆
$12M invest funds EAI targeting 1K deliveries + margin, warrant post-500 FX Super One
- First Interstate/Optimization↓(OPPORTUNITY)◆
2025 BVPS $34, returns 103% NI via divs/buybacks, NIM expansion/cost of funds -360 bps to 1.47%
- Yum China/Exec Comp↓(OPPORTUNITY)◆
2025 OP +11%, EPS +14%, STI payouts 210-244% target, Pizza Hut margin 7.9% highest since 2016
Sector Themes(6)
- Financials Q1 Profit Surge(BULLISH FINANCIAL SECTOR)◆
6/10 banks/insurers (Travelers, BancFirst, US Bancorp, BNY, Bank First) posted +10-333% YoY NI avg +90%, NII +5-46% but NIM flat/compress (Bank First -120 bps QoQ), implies resilient credits but deposit pressure
- Insurance Premium/Margin Stress(MIXED INSURANCE)◆
Travelers NWP -2% YoY, Personal Ins -9%, combined ratio +1.6 pts to 89.8%; contrasts cat loss drop -66% to $761M, supports buyback/div growth
- Capital Returns Acceleration(BULLISH SHAREHOLDER VALUE)◆
4 firms hiked divs +10-22% YoY (Travelers 14%, Bank First 22%), buybacks $2B+ Q1 (Travelers $2B, First Interstate 103% NI), $5B+ remaining auth, signals conviction amid BV growth
- Small-Cap Distress/Dilution(BEARISH MICRO-CAPS)◆
8/20 microcaps show revenue -100% to -20% YoY (Vipshop -2%, JOCOM -100%), dilution via preferred/registrations (RenovoRx 16M shrs, Visium Series E 40% FD), auditor delays/changes
- Biotech Clinical Momentum(BULLISH BIOTECH CATALYSTS)◆
MeiraGTx 2 filings: 3-yr xerostomia data +17pt improvement + J&J XLRP asset (Phase3 hits), $25M upfront/$3.7B potential, outliers vs sector
- Proxy/AGM Cluster May-Jun(NEUTRAL GOVERNANCE)◆
15+ DEF14A/DEFA14A for AGMs May18-Jun10 (Travelers implied, Immunocore May27, Yum China May27, Glaukos May28), routine approvals but watch comp votes/exec changes
Watch List(8)
Q1 +333% NI but premiums -2%, combined ratio +1.6pts, monitor Q2 cat losses/buyback pace post-$5.2B auth, next earnings ~Jul2026
BDO replacement post-Deloitte, material weaknesses ongoing, watch 8-K amendment/Deloitte letter by ~Apr26 for restatement risk
Warrant exercisable post-500th FX Super One delivery 2026, track EAI robotics 1K deliveries for margin inflection
- Immunocore AGM👁
May27 2026 London hybrid, vote directors/auditors/comp, record May22, potential sentiment from approvals
Post-3yr data + J&J asset, watch BLA/approval paths for 2027 xerostomia/XLRP launches est $2-3.7B peak
- Yum China AGM👁
May27 2026, approve directors/auditors/share issuance 20%/repurchase 10%, record date prior, monitor China sales guidance
- Katapult Covenants👁
Post-10th waiver, watch Q2 net originations/charge-offs vs thresholds, potential 11th waiver signal
- Multiple AGMs (Glaukos May28, First Interstate May27, Cathay May18)👁
Cluster votes on comp/auditors/directors, track say-on-pay advisory for exec retention
Filing Analyses(50)
16-04-2026
Horizon Quantum Holdings Ltd. filed an F-1 registration statement in connection with its proposed business combination with DMY Technology Group via SPAC merger, approved by DMY shareholders on March 17, 2026, with a minimum cash condition of $45M and PIPE financing of $111.9M including from IonQ. However, the company faces significant challenges including a net loss of $17.8M for the year ended December 31, 2025, a working capital deficit of $8.2M, delisting from NYSE American to OTC markets, and substantial doubt about going concern due to liquidity issues and mandatory liquidation risk by March 29, 2026.
- ·Delisted from NYSE American on September 29, 2025, now trading on OTCQB (Class A common stock and Public Warrants as DMYY/DMYYW) and OTCID (Units as DMYYU).
- ·SEC declared F-4 effective February 17, 2026; DMY Definitive Proxy filed same day.
- ·Convertible Note to Sponsor affiliate up to $1.75M principal, proceeds contributed to Trust Account.
- ·Management concluded Excise Tax applicability for 2024 redemptions in 2025, but no expense for 2025 redemptions below $1M de minimis.
- ·Expected business combination closing subject to redemptions, regulatory approvals; no assurance of timeline.
16-04-2026
RenovoRx, Inc. (RNXT) filed an S-3 registration statement on April 16, 2026, to register 15,958,182 shares for resale by selling stockholders from the March 2026 Private Placement, which raised approximately $10 million in gross proceeds. The company could receive up to $9.3 million from cash exercises of Milestone Warrants covering 5,319,392 shares. However, the filing highlights risks of immediate dilution, high stock volatility (closing prices ranged from $0.73 to $1.42 per share from March 20, 2025 to March 20, 2026), and potential downward pressure on the stock price from sales of these shares.
- ·Purchase price per share and Milestone Warrant for Institutional Investors: $0.938; for Insiders: $1.0288.
- ·Milestone Warrant exercise prices: $1.751 per share for Institutional Investors, $1.9326 for Insiders; expire March 30, 2029 or 30 days after $1.5M quarterly product sales.
- ·Pre-Funded Warrants exercisable at $0.0001 per share and do not expire.
- ·Selling stockholders include institutional investors like AIGH Investment Partners LP (4.99% ownership before offering) and Transcend Partners LLC (4.99%).
16-04-2026
LanzaTech Global, Inc. dismissed Deloitte & Touche LLP as its independent registered public accounting firm on April 10, 2026, and engaged BDO USA, P.C. as the replacement, both approved by the Audit Committee. Deloitte's audit reports for fiscal years 2024 and 2025 included going concern doubts and references to previously disclosed material weaknesses in internal controls over financial reporting, with no disagreements or reportable events beyond those. The change highlights ongoing control issues but did not lead to financial restatements.
- ·Material weaknesses related to accounting for complex transactions/estimates, revenue recognition (2024), and control activities, monitoring, risk assessment, information/communication (2025).
- ·Deloitte authorized to respond to successor auditor on material weaknesses.
- ·Deloitte letter to SEC to be filed as exhibit to 8-K amendment within 10 business days.
16-04-2026
Travelers Companies reported excellent Q1 2026 net income of $1.711 billion (+333% YoY) and core income of $1.696 billion (+283% YoY), with core ROE of 19.7%, driven by lower catastrophe losses ($761 million pre-tax vs. $2.266 billion prior year) and higher net investment income ($833 million after-tax, +9%). The company returned $2.223 billion to shareholders including $1.985 billion in repurchases and declared a 14% dividend increase to $1.25 per share. However, net written premiums fell 2% YoY to $10.338 billion, with Personal Insurance down 9%, and underlying combined ratios deteriorated in Business Insurance (+1.6 pts to 89.8%) and Bond & Specialty Insurance (+1.6 pts to 88.9%).
- ·Book value per share $150.42, down 1% from Dec 31, 2025.
- ·Adjusted book value per share $161.60, up 2% from Dec 31, 2025.
- ·Remaining share repurchase authorization capacity $5.215 billion as of March 31, 2026.
- ·Quarterly dividend payable June 30, 2026 to shareholders of record June 10, 2026.
- ·Canadian operations divested in Q1 2026, impacting prior year premium comparisons.
16-04-2026
Faraday Future Intelligent Electric Inc. amended its securities purchase agreement with Gold King Arthur Holding Limited, a purchaser designated by AIxCrypto Holdings Inc., increasing the total investment from $10 million to $12 million, consisting of $500,000 in common stock (1,923,077 shares at $0.26 per share) and $11.5 million in convertible Series C preferred stock. The amendment eliminates the anti-dilution true-up provision, replacing it with a warrant to purchase up to 1,000,000 shares of common stock at $1.50 per share (4-year term, exercisable after delivery of the 500th FX Super One vehicle), which the company views as favorable to existing stockholders. Proceeds will fund the EAI robotics business targeting 1,000 deliveries with positive contribution margin and FX Super One advancement in 2026.
- ·Per share purchase price revised to average closing price of 10 trading days prior to April 14, 2026 signing date: $0.26
- ·Warrant exercise price: $1.50 per share; term: 4 years
- ·Initial Agreement dated February 4, 2026
- ·AIxC pre-funded the $12 million on behalf of the investor
16-04-2026
Immunocore Holdings plc has filed its DEF 14A proxy statement for the 2026 Annual General Meeting (AGM) on May 27, 2026, at 2:00 p.m. London time, held hybrid in London and via meetnow.global/IHCAGM2026, seeking shareholder approval via ordinary resolutions for re-appointing directors Siddharth Kaul, William Pao M.D. Ph.D., and Kristine Peterson; advisory vote on named executive officer compensation; ratification and re-appointment of Deloitte LLP as U.S. and U.K. auditors; adoption of the 2025 U.K. annual report and directors' remuneration report; and authorization for political donations/expenditures up to £50,000 each to parties, organizations, or incurred directly. The board recommends voting in favor of all resolutions, with voting by poll and record date of May 22, 2026 at 6:00 p.m. London time for ordinary shares.
- ·Ordinary share record date for AGM voting: May 22, 2026, 6:00 p.m. London time (1:00 p.m. EDT)
- ·ADS holder record date: April 2, 2026, 5:00 p.m. EDT
- ·Proxy submission deadline: May 22, 2026, 2:00 p.m. London time (9:00 a.m. EDT)
- ·Political donation/expenditure authority period: from AGM to 2027 AGM or May 27, 2027, whichever later
16-04-2026
AIxCrypto Holdings, Inc. amended its Entrusted Investment Agreement with GOLD KING ARTHUR HOLDING LIMITED (GKA) and Song Wang to expand the definition of FFAI Shares to include preferred stock, loans, debt, and convertible notes, while removing certain share charges and call options. Concurrently, the Securities Purchase Agreement with Faraday Future Intelligent Electric Inc. (FFAI) was amended and restated, increasing the subscription amount from $10 million to $12 million ($500,000 for Class A Common Stock and $11.5 million for 11,502 shares of Series C Convertible Preferred Stock at $0.26 per share equivalent), eliminating True-Up Shares in exchange for a warrant for 1,000,000 FFAI Class A shares, with the deal closing on April 15, 2026. A $2 million loan from GKA to FFAI at 10% interest was provided and subsequently terminated upon closing.
- ·Loan matures one year from funding date and is unsecured; terminated upon SPA closing.
- ·FFAI Warrant term: 4 years; exercisable after delivery of 500th FX Super One vehicle; beneficial ownership limit: 9.99%; aggregate issuance limit: 19.99% of outstanding Class A shares pre-SPA.
- ·Alternate Conversion option at lower of conversion price or max($0.13, prior day close).
16-04-2026
Bank First Corp reported Q1 2026 net income of $20.0 million ($1.78 per share), up 9.9% YoY from $18.2 million ($1.82 per share), with adjusted net income of $25.1 million ($2.24 per share) after $6.5 million in Centre acquisition expenses; NII rose 45.8% YoY to $53.2 million, driven by the $1.48 billion Centre acquisition that boosted assets 33% to $6.07 billion, loans to $4.52 billion, and deposits to $5.09 billion. However, NIM compressed 1.2% QoQ to 3.96%, noninterest expenses surged 89% QoQ to $39.1 million due to integration costs, and nonperforming assets doubled QoQ to $30.0 million (0.50% of assets) amid a single large nonaccrual and Centre-related assets. The board declared a quarterly dividend of $0.55 per share, up 10.0% QoQ and 22.2% YoY.
- ·Six overlapping First National Bank and Trust branches permanently closed post-acquisition.
- ·Planning new offices in Walworth, Delavan, and Monroe; consolidating two additional branches.
- ·Core deposit intangible from Centre: $31.9 million, amortized over 10 years.
- ·FHLB borrowings repaid: $65.0 million, with $1.1 million prepayment penalty.
- ·Centre loans reduced from $981.5 million acquired to $936.7 million at quarter-end due to transitions.
- ·No provision for credit losses Q1 2026 vs $0.2 million YoY, after $12.8 million ACL addition from acquisition.
- ·Tangible book value per share: $47.04 (up from $46.01 at Dec 31 2025).
16-04-2026
First Business Financial Services, Inc. appointed David R. Seiler, current President and COO since January 2023, as President, Chief Executive Officer, and Class III Director effective May 3, 2026, succeeding retiring CEO Corey A. Chambas whose retirement was announced in May 2025. The appointment coincides with a new five-year employment agreement providing a minimum annual base salary of $600,000, eligibility for incentive plans, and a $215,000 restricted stock unit grant vesting over five years. The agreement includes standard severance provisions, such as two times base salary upon termination without cause, and customary restrictive covenants.
- ·Employment agreement effective May 3, 2026, with initial 5-year term and automatic 1-year renewals unless 60 days' notice
- ·RSU vesting schedule: 15% on each of first four anniversaries, 40% on fifth anniversary, subject to continued employment
- ·Severance for termination without Cause or for Good Reason: 2x then-current base salary over 24 months, prorated incentive, 18 months health coverage
- ·Mr. Seiler has over 30 years of financial services experience; prior Managing Director at BMO Harris Bank
- ·Appointment to Board as Class III Director until 2028 Annual Meeting
16-04-2026
DISCIPLINED GROWTH ACQUISITION Corp, a blank check company, filed an S-1 registration statement on April 16, 2026, exempt from SEC Rule 419, allowing immediately tradable units and extended time for initial business combination. Key risks include only $1,000,000 available outside the trust account for operations, estimated offering expenses of $650,000, up to $1,500,000 in potential convertible loans from sponsor at $10.00 per unit, and restrictions on redeeming more than 15% of Class A ordinary shares per shareholder/group. Additional concerns involve intense competition for targets, limited resources, and potential reduction of trust account below $10.00 per share due to third-party claims despite sponsor indemnification.
- ·Sponsor liable for third-party claims reducing trust below $10.00 per share (except auditors and waived claims), but no reserved funds verified
- ·Independent directors may not enforce sponsor indemnification if costs too high
- ·Claims against trust account possible within 10 years post-redemption
- ·Prior to business combination, loans sought only from sponsor or affiliates
16-04-2026
BancFirst Corporation reported Q1 2026 net income of $63.0 million (up 12.3% YoY from $56.1 million) and diluted EPS of $1.85 (up from $1.66), driven by net interest income growth to $127.6 million (up 10.0% YoY) and noninterest income of $51.4 million (up 5.1% YoY), with NIM expanding to 3.74% from 3.70%. However, noninterest expense increased to $96.8 million (up 5.0% YoY) due to higher salaries and benefits, provision for credit losses rose to $2.1 million (from $1.6 million), and net charge-offs increased to $1.5 million (from $0.5 million). Balance sheet grew with total assets at $15.1 billion (up $0.3 billion QoQ), loans at $8.6 billion (up $0.1 billion QoQ, but modest YoY), and deposits at $12.9 billion (up $0.2 billion QoQ).
- ·Nonaccrual loans remained flat at 0.72% of total loans QoQ and totaled $62.2 million at March 31, 2026.
- ·Net charge-offs were $1.5 million in Q1 2026 vs $0.5 million in Q1 2025.
- ·Allowance for credit losses to total loans was 1.23% at March 31, 2026 (up slightly from 1.22% at Dec 31, 2025).
- ·Insurance commissions declined to $9.4 million in Q1 2026 from $10.4 million in Q1 2025.
16-04-2026
First Interstate BancSystem, Inc. filed its 2026 Proxy Statement for the Annual Meeting on May 27, 2026, seeking shareholder approval to elect three directors, amend the Charter for plurality voting in contested elections, approve NEO compensation on an advisory basis, and ratify Ernst & Young LLP as auditors for 2026. 2025 financial highlights include net income of $302.1 million, diluted EPS of $2.94, ROAE of 8.83%, ROATCE of 13.53%, BVPS of $34.09, TBVPS of $22.40, and shareholder returns of $311.9 million (103% of net income) via $1.88 per share dividends and $117.6 million in share repurchases (3,653,914 shares at $32.18 average). Strategic progress featured branch optimizations (sales/closures in AZ, KS, NE, MN, ND), outsourcing consumer credit cards, discontinuing indirect loans, reducing borrowed funds from $1.6 billion to zero, and expanding NIM sequentially with cost of funds declining to 1.47% from 1.83% in 2024.
- ·Record date: April 2, 2026
- ·Annual meeting location: First Interstate Center, 401 N. 31st Street, Billings, Montana 59101 at 4:00 p.m. MT
- ·Completed sale of Arizona and Kansas branches in 2025; 11 Nebraska branches closed April 2026; six branches closed February 2026 in Minnesota, Nebraska, North Dakota
- ·Outsourced consumer credit card portfolio and discontinued originating indirect loans in 2025
16-04-2026
Valued Advisers Trust is holding a special shareholder meeting on May 8, 2026, for the LS Opportunity Fund to approve a sub-advisory agreement between Long Short Advisors, LLC (Adviser) and Grantham, Mayo, Van Otterloo & Co. LLC (Sub-Adviser), and to authorize reliance on a Manager of Managers order; the Board unanimously recommends voting FOR both proposals following their approval on March 23-24, 2026. The Sub-Adviser, with over $82 billion in assets under management as of February 28, 2026, will receive 50% of the 1.75% total advisory fee up to $200M in assets (shifting to 52% above), at the Adviser's expense. No performance declines or flat metrics are noted in the filing.
- ·Record date: March 25, 2026
- ·Sub-Advisory Agreement initial term: two years, with annual renewals subject to Board and shareholder approval
- ·Adviser location: 3330 Fairchild Gardens Avenue, Suite 30428, Palm Beach Gardens, FL 33420
- ·Sub-Adviser location: 53 State Street, Suite 3300, Boston, Massachusetts 02109
- ·Fund offices: 225 Pictoria Dr., Suite 450, Cincinnati, OH 45246
- ·Exclusivity arrangement: Sub-Adviser commits to exclusivity with Adviser for similar pooled investment vehicles
- ·Proxy materials available at: vote.proxyonline.com/vat/docs/LS2026mtg.pdf
- ·Voting hotline: (800) 859-8511 (Mon-Fri, 9:00 a.m. to 10:00 p.m. ET)
16-04-2026
Visium Technologies, Inc. filed a Certificate of Designation creating Series E Convertible Preferred Stock with a Stated Value of $750 per share, convertible into 15,000 shares of Common Stock at a fixed $0.05 Conversion Price, designed to represent 40% of fully diluted equity upon issuance at Closing per a March 29, 2026 Letter of Intent. The series offers an 8% cumulative dividend (cash or PIK) and ranks senior to Common Stock for dividends and liquidation (non-participating), but junior to Series AA and G Preferred; however, it imposes significant dilution on existing common shareholders and includes protective provisions requiring majority Series E consent for adverse changes. Company redemption is possible post-$10M Qualifying Transaction at 103% of Stated Value plus dividends, with voting capped at 4.99%.
- ·Par value of Series E Preferred Stock: $0.001 per share; Common Stock: $0.0001 per share.
- ·No anti-dilution protection for price-based Dilutive Issuances.
- ·Redemption exercisable only after Qualifying Transaction of $10,000,000 or greater.
16-04-2026
Valaris reported strong 2025 financial performance with net income of $979.1 million, Adjusted EBITDA of $642.2 million, cash from operations of $546.2 million, and Adjusted Free Cash Flow of $340.6 million, alongside fleetwide revenue efficiency of 96% for the fifth consecutive year. The company secured $2.6 billion in contract backlog during 2025 and an additional $900 million since early 2026, sold rigs for over $130 million in proceeds, and repurchased $100 million in shares. This proxy statement for the June 10, 2026 AGM seeks approval for director elections, NEO compensation, and KPMG as auditors, amid a pending all-stock acquisition by Transocean announced in February 2026.
- ·Annual General Meeting scheduled for June 10, 2026, at 8:00 a.m. Bermuda time in Hamilton, Bermuda.
- ·Record date for voting: April 13, 2026.
- ·Resolutions: (1) Election of six director nominees; (2) Advisory vote on NEO compensation; (3) Approval of KPMG LLP as independent auditor.
- ·Pending all-stock business combination with Transocean announced February 9, 2026, subject to shareholder and regulatory approvals; separate Scheme Meeting to be held.
16-04-2026
Valaris Limited filed a DEFA14A Definitive Additional Materials proxy statement on April 16, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as definitive additional materials for proxy solicitation. No specific proposals, financial data, or other substantive details are included in the provided content.
16-04-2026
SEATech Ventures Corp. reported no revenue in 2025, unchanged from 2024, but narrowed its net loss to $39,341 from $156,926 YoY, a 75% improvement driven by $57,961 in other income (gains from disposals) and reduced G&A expenses to $97,302 from $157,382. However, total assets declined 46% to $10,484 from $19,571, cash and equivalents dropped 96% to $465, and net cash used in operations worsened to $50,073 from $39,982. Stockholders' deficit improved slightly to $(381,466) from $(385,173).
- ·Plans to enhance internal controls by creating positions for duty segregation and improving accounting expertise.
- ·Issuance of 42,500 common shares in 2025 for $42,500.
- ·Cancellation of 21,831,660 shares in 2024 related to termination of acquisition of Just Supply Chain Limited.
- ·Accounts receivable from related parties (catTHIS Holdings Corp.) at $0 both periods, net of $115,000 allowance.
16-04-2026
First Financial Bancorp's DEF 14A Proxy Statement for the May 26, 2026 virtual Annual Meeting seeks shareholder approval for electing 10 directors, ratifying Crowe LLP as 2026 independent auditors, approving the 2026 Stock Plan, and an advisory vote on executive compensation; record date is March 27, 2026. The company reports strong 2025 performance with record revenue and noninterest income, completion of Westfield Bank acquisition adding 8 financial centers in northeast Ohio, and an agreement to acquire BankFinancial Corporation. Community initiatives included $4.6 million in grants/donations and over 16,300 associate volunteer hours, with no material declines noted.
- ·Annual Meeting at 10:00 AM Eastern Time on May 26, 2026, virtually at virtualshareholdermeeting.com/FFBC2026
- ·Shareholders of record as of March 27, 2026 eligible to vote
- ·5-star rating from Bauer Financial; Investment Grade rating from Kroll Bond Rating Agency
- ·Received Gallup Exceptional Workplace Award and second consecutive Outstanding CRA rating from Federal Reserve Board
16-04-2026
Hooker Furnishings reported fiscal 2026 Q4 net sales of $67.0 million, down 20.5% YoY due to a shorter quarter, lower hospitality shipments, and weather disruptions, but achieved Q4 operating income of $0.6 million and net income of $0.536 million from continuing operations. Full-year net sales declined 12.4% to $278.1 million, with an operating loss of $16.5 million primarily from $15.6 million in non-cash impairments, offset by gross margin expansion of 180 basis points, SG&A reduction of $11.9 million, and fixed cost cuts of $26.3 million. The company completed divestitures of Pulaski Furniture and Samuel Lawrence Furniture, authorized a $5 million share repurchase program, and adjusted its annual dividend to $0.46 per share.
- ·Cash and equivalents at $1.1M FY26 end, down $5.2M YoY; revolver reduced by $18.5M to $3.6M.
- ·As of April 15, 2026: $12M cash, $64.1M available borrowing capacity, no credit facility balance.
- ·$17.5M of fixed cost savings related to continuing operations.
- ·Hooker Branded incoming orders flat YoY; Domestic Upholstery incoming orders down 1.9% YoY.
- ·Evaluating potential tariff duty refunds post U.S. Supreme Court ruling in February 2026.
- ·Annual dividend recalibrated to $0.46 per share.
16-04-2026
TB Alternative Assets Ltd. disclosed its quarterly 13F-HR holdings as of March 31, 2026, totaling $481,084,856 across 36 positions, filed on April 16, 2026. Key holdings include Meta Platforms Inc Cl A at $77,237,550, ProShares TR II Ultra Gold at $42,883,039, PDD Holdings Inc at $34,764,497, Figure Technology Solutio Com Cl A at $33,862,850, and Occidental Pete Corp at $33,455,630. The portfolio spans technology, energy, leveraged ETFs, and Chinese ADRs with no period-over-period changes reported in this filing.
- ·Report period end date: March 31, 2026
- ·Filing date: April 16, 2026
- ·Filer CIK: 0001483503
- ·Investment manager CRD: 162014
- ·Headquartered in Grand Cayman, with mailing address in Hong Kong
- ·Includes positions in energy (e.g., Exxon Mobil 79,653 shares, Energy Transfer LP 251,006 shares), Chinese ADRs (e.g., SO-Young International 3,067,873 shares), and semiconductors (e.g., Taiwan Semiconductor 27,000 shares)
16-04-2026
Cathay General Bancorp (CATY) has issued its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on May 18, 2026 at 5:00 p.m. PT, with a record date of March 26, 2026. Stockholders are asked to elect four Class III directors (Nelson Chung, Felix S. Fernandez, Maan-Huei Hung, Richard Sun) to serve until 2029, approve executive compensation on an advisory basis, vote on holding future say-on-pay votes every year, and ratify KPMG LLP as the independent auditor for fiscal 2026. The Board recommends FOR all director nominees, FOR executive compensation, EVERY YEAR for frequency, and FOR auditor ratification; 66,972,039 shares of common stock were outstanding on the record date.
- ·Quorum requires majority of outstanding shares present in person or by proxy.
- ·Voting deadline via Internet/telephone: 11:59 p.m. ET on May 17, 2026.
- ·ESOPT shares voting instructions due by 11:59 p.m. ET on May 13, 2026.
- ·Proposals 1-3 are non-routine (broker non-votes possible); Proposal 4 is routine.
- ·Directors elected by majority of votes cast.
16-04-2026
Glaukos Corporation (GKOS) has filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting scheduled for May 28, 2026, at 9:00 AM PDT virtually. Shareholders are to vote on the election of directors Denice M. Torres and Aimee S. Weisner, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors for the year ending December 31, 2026. Voting deadline is May 27, 2026, 11:59 PM ET, with proxy materials available online or requestable by May 14, 2026.
- ·Virtual meeting access: www.virtualshareholdermeeting.com/GKOS2026
- ·Proxy material requests via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com (include control number)
- ·Address: ONE GLAUKOS WAY, ALISO VIEJO, CA 92656
16-04-2026
AMC Robotics Corporation issued a press release on April 15, 2026, announcing a delay in filing its Annual Report on Form 10-K for the year ended December 31, 2025. This disclosure was furnished under Item 7.01 of Form 8-K and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
- ·Common Stock: par value $0.0001 per share, trading symbol AMCI on The Nasdaq Stock Market LLC
- ·Registrant is an emerging growth company
16-04-2026
Glaukos Corporation's DEF 14A Proxy Statement, filed April 16, 2026, solicits stockholder votes for the 2026 Annual Meeting on May 28, 2026, to elect two Class II directors until 2029, approve named executive officer compensation on an advisory basis, and ratify Ernst & Young LLP as independent auditors for 2026. The company highlights 2025 net sales of $507M and cash, equivalents, restricted cash, and short-term investments of $283M as of December 31, 2025, while operating in 17 countries with over 300 global commercial personnel. No period-over-period comparisons or performance declines are disclosed in the provided content.
- ·Record date: April 2, 2026
- ·Annual Meeting: May 28, 2026, 9:00 a.m. Pacific Time, virtual webcast at www.virtualshareholdermeeting.com/GKOS2026
- ·Proxy materials first available: on or about April 16, 2026
16-04-2026
Cyber Enviro-Tech, Inc. (CETI) announced a delay in filing its 10-K annual report until at least April 28, 2026, due to auditors requiring an Independent Fairness Opinion for a discontinued former subsidiary operation disclosed in its Q3 2025 filing. The company has retained an independent expert to comply and holds a draft version of the 10-K, expressing hope for an expedited filing. This development signals potential audit complications with no financial data released.
- ·Auditors notified CETI of the Fairness Opinion requirement recently.
- ·Company has committed to supplying additional documentation if requested by auditors.
- ·CETI trades on OTCQB under symbol CETI (Class A Common Stock).
16-04-2026
Equitable Holdings, Inc. is exploring repurchases of its common stock prior to the closing of its pending merger with Corebridge Financial, Inc., announced on March 26, 2026, potentially during the period from the SEC filing of the preliminary proxy statement/prospectus until its mailing. The company would need a waiver from Corebridge under the merger agreement to proceed, but there is no assurance that repurchases will occur or any details on volume, pricing, timing, or method. The disclosure includes extensive forward-looking statement cautions regarding risks, uncertainties, and potential failure to complete the merger.
- ·Securities registered: Common Stock (EQH, NYSE), Depositary Shares each representing 1/1,000th interest in Fixed Rate Noncumulative Perpetual Preferred Stock Series A (EQH PR A, NYSE), Series C (EQH PR C, NYSE)
- ·Merger agreement prohibits share repurchases during pendency without waiver
16-04-2026
Herbalife Ltd. announced the pricing of an offering by subsidiaries HLF Financing SaRL, LLC and Herbalife International, Inc. of $800 million aggregate principal amount of 7.750% senior secured notes due 2033, priced at 100.00% of par. The net proceeds, combined with refinancing of the existing senior secured credit facility and available cash, will repay indebtedness including borrowings under the credit facility and the Issuers’ 12.250% Senior Secured Notes due 2029, plus related fees. The offering is expected to close on April 29, 2026, subject to customary conditions.
- ·Notes bear interest paid semi-annually on May 1 and November 1, commencing November 1, 2026.
- ·Notes guaranteed on a senior secured basis by Herbalife Ltd. and its existing and future subsidiaries that guarantee the senior secured credit facility.
- ·Offering conducted pursuant to Rule 144A and Regulation S; not registered under Securities Act.
- ·Press release issued April 15, 2026.
16-04-2026
Lincoln Educational Services Corporation (Nasdaq: LINC) entered into an amended and restated revolving credit facility, increasing the aggregate principal amount from $60 million to $125 million, with a $10 million letter of credit sublimit and a $25 million accordion feature, maturing on April 11, 2031. This provides $65 million in additional liquidity to support growth initiatives. CEO Scott M. Shaw noted 19-20% student start growth in Q1 2026, underscoring successful strategy execution amid a strong balance sheet.
- ·Credit facility term of five years.
- ·Operates campuses under three brands since inception in 1946.
- ·Amended facility with Fifth Third Bank as administrative agent, joint lead arranger, and joint bookrunner.
16-04-2026
Catalyst Crew Technologies Corp. (CCTC) reported a sharply reduced net loss of $207,485 for the year ended December 31, 2025, compared to $3,261,038 in 2024, primarily due to operating expenses dropping 95% to $171,852 from $3,297,858. However, revenue remained at $0 for both years, total liabilities increased 10% to $630,860 from $573,575, and the company continued to hold zero cash and total assets. Stockholders' deficit widened to match liabilities at $630,860.
- ·Common shares outstanding increased to 44,296,895 from 29,276,895, including 15,020,000 shares issued for cash raising $150,200.
- ·Cash and total assets remained at $0 as of December 31, 2025 and 2024.
- ·Net loss per common share improved to $(0.01) from $(0.11).
- ·Deferred income tax assets of $6,216,165 fully offset by valuation allowance as of Dec 31, 2025.
16-04-2026
Global Net Lease, Inc. filed a Form 8-K on April 16, 2026, under Items 7.01 and 9.01, furnishing a press release dated April 16, 2026, as Exhibit 99.1. The filing discloses securities registered on the NYSE, including Common Stock (GNL) and various Series A, B, D, and E Preferred Stocks. The report was signed by Edward M. Weil, Jr., Chief Executive Officer and President.
16-04-2026
JOCOM HOLDINGS CORP's total assets increased 91.5% YoY to $15,840 as of December 31, 2025, primarily due to cash rising 352% to $11,220 from $500,000 in stock issuances. However, revenue dropped 100% to $0 from $24,000, leading to a net loss of $844,160 versus a prior-year profit of $68,519, with G&A expenses surging to $937,220 and operating cash burn of $491,306. Stockholders' equity worsened to -$106,240 from -$68,561 amid impairments of $648,000 and subsidiary closure.
- ·Common shares increased to 65,680,500 from 57,680,500 via unregistered sales of 8M shares in June 2025 at $0.10/share netting $800,000 proceeds.
- ·Other payables and accruals rose to $120,700 (incl. $92,487 to related party) from $69,434 (incl. $26,464 to related party).
- ·Intangible asset fully impaired to $0 from $1.
- ·Loss from discontinued operations: $4,318 in 2025.
- ·Weighted average shares basic/diluted: 64,632,881 in 2025.
16-04-2026
Sentient Brands Holdings Inc. reported its first full-year sales of $701,463 in 2025, generating a gross profit of $192,437 versus no sales and a $153,155 gross loss in 2024; total assets surged to $2,594,237 from $23,297, fueled by $1,167,872 in intangible assets and $532,473 in goodwill from acquisitions. However, operating expenses increased 53% YoY to $1,210,178, resulting in a larger net loss of $1,201,577 (vs. $904,624 in 2024) and ongoing stockholders' deficit of $(2,105,519), though improved slightly from $(2,732,945). Basic and diluted EPS improved to $(0.32) from $(0.38) due to share issuance.
- ·Cash increased to $29,011 from $3,432.
- ·Accounts receivable of $423,138 emerged in 2025 (none in 2024).
- ·Convertible notes payable decreased to $715,789 from $809,047.
- ·Derivative gain of $98,653 in 2025 vs. $381,246 in 2024.
- ·Legal and professional expenses rose to $605,795 from $557,408.
- ·Management fees increased to $497,345 from $217,810.
16-04-2026
For the year ended December 31, 2025, China Foods Holdings Ltd. reported revenue growth of 40.5% YoY to $327,871, driven by Healthcare segment expansion to $327,107 from $125,548, while Wine segment revenue plummeted 99.3% to $764. However, gross profit declined 44.2% YoY to $29,962, net loss narrowed to $(398,672) from $(455,571), total assets halved to $212,890 from $435,005, and total liabilities rose 16.0% to $1,490,361, with shareholders' deficit worsening to $(1,277,471). Customer concentration increased to 94% from three customers, posing risks.
- ·Net cash used in operating activities increased to $(389,251) from $(353,812).
- ·Net cash provided by financing activities rose to $388,605 from $245,524.
- ·Customer concentration: top customer Hunan Wuyouzhongle rose to 50% of revenues ($163,601) from 43% ($101,470).
- ·Prepayments, deposits and other receivables declined sharply to $108,388 from $302,997.
- ·Amount due to directors increased to $474,102 from $360,858.
- ·No accounts receivable from top customers in either year.
16-04-2026
Yum China Holdings, Inc. (YUMC) filed a DEFA14A proxy statement for its Annual Meeting of Stockholders, seeking approval for the election of 12 director nominees, ratification of KPMG Huazhen LLP and KPMG as independent auditors for 2026, an advisory vote on executive compensation, authorization for the Board to issue shares up to 20% of outstanding shares, and authorization to repurchase shares up to 10% of outstanding shares. The Board recommends voting 'FOR' all proposals. Voting must be completed by 11:59 a.m. Beijing/Hong Kong time on May 27, 2026 (11:59 p.m. ET on May 26, 2026), with material requests due by May 14, 2026.
- ·Proxy materials available online at www.ProxyVote.com or by request via phone (1-800-579-1639) or email (sendmaterial@proxyvote.com) by May 14, 2026.
- ·Proxies authorized to vote at discretion on other business at the meeting or any adjournment.
16-04-2026
Katapult Holdings, Inc. entered into the Tenth Limited Waiver to its Amended and Restated Loan and Security Agreement on April 15, 2026, in response to defaults including failure to maintain Minimum Trailing Three-Month Net Originations as of March 31, 2026, and excess charge-offs in collateral leases exceeding thresholds. The waiver permanently excuses the existing default and prevents advance rate reductions. This marks the tenth such waiver since the original agreement dated June 12, 2025, signaling ongoing covenant compliance challenges.
- ·Previous waivers include: First (Sep 15, 2025), Second (Sep 29, 2025), Third (Oct 13, 2025), Fourth (Oct 20, 2025), Fifth (Oct 27, 2025), Sixth (Oct 29, 2025), First Amendment (Nov 2, 2025), Second Amendment (Dec 11, 2025), Seventh (Jan 15, 2026), Eighth (Feb 13, 2026), Ninth (Mar 9, 2026).
16-04-2026
Yum China Holdings, Inc.'s 2026 DEF 14A Proxy Statement details exceptional 2025 executive performance, driving 11% operating profit growth, 14% diluted EPS increase (excluding FX and mark-to-market equity investments impact of -$0.06), and 4% system sales growth (excluding FX). CEO Ms. Wat received a 2025 STI payout of $6,156,000 (216% of $2.85M target due to 180% team factor and 120% individual factor), with other NEOs receiving 210-244% of targets; 2025 LTI grants totaled $14.7M across NEOs, unchanged at $10M for the CEO. KFC and Pizza Hut achieved 5% and 4% system sales growth (ex-FX), 8% and 19% operating profit growth, respectively, with strong store expansion and delivery sales up 26% and 22% YoY.
- ·Pizza Hut OP margin reached 7.9% in 2025, highest since 2016 listing
- ·Company average commodity inflation 0.97x relative to China CPI Food Index from 2023-2025
- ·Mark-to-market equity investments impacted diluted EPS by -$0.06 in 2025 vs +$0.08 in 2024
- ·KFC delivery sales contributed 48% of Company sales; Pizza Hut 47% in 2025
16-04-2026
Coca-Cola Europacific Partners plc (CCEP) issued a release on April 16, 2026, announcing the availability of proxy materials for its 2026 Annual General Meeting (AGM) scheduled for May 28, 2026, including the Notice of AGM, Form of Proxy, and Amended Long Term Incentive Plan Rules, filed as Exhibits 99.1, 99.2, 99.3, and 4.1. The company operates across 31 countries, serving nearly 600 million consumers and over 4 million customers. No financial performance metrics or period comparisons were disclosed in the filing.
- ·CCEP listed on Euronext Amsterdam, NASDAQ, London Stock Exchange, and Spanish Stock Exchanges; constituent of NASDAQ 100 and FTSE 100 indices; trading symbol CCEP (ISIN GB00BDCPN049).
- ·Principal executive offices: Pemberton House, Bakers Road, Uxbridge, UB8 1EZ, United Kingdom.
- ·Contact emails: svetlana.walker@ccep.com, sarah.willett@ccep.com, mediaenquiries@ccep.com.
16-04-2026
U.S. Physical Therapy, Inc. (USPH) has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders on May 19, 2026, proposing the election of seven directors, including new nominee Peter F. Minan to replace retiring directors Nancy J. Ham and Clayton K. Trier, with no reported controversies. Stockholders will also consider an advisory vote to approve named executive officer compensation and ratification of Grant Thornton LLP as independent auditors for the year ending December 31, 2026. The record date is March 25, 2026, and the Board recommends voting in favor of all proposals.
- ·Annual Meeting location: 1300 West Sam Houston Parkway South, Suite 300, Houston, Texas 77042 at 9:00 a.m. Central Time
- ·Record date: March 25, 2026
- ·Director ages: Christopher J. Reading (62), Kathleen A. Gilmartin (74), Dr. Bernard A. Harris, Jr. (69), Anne B. Motsenbocker (64), Regg E. Swanson (72), Michael G. Mayrsohn (39), Peter F. Minan (64)
- ·Proxy materials available at http://materials.proxyvote.com/90337L
16-04-2026
U.S. Bancorp reported 1Q26 net revenue of $7,288 million, up 4.7% YoY driven by 4.1% growth in net interest income and 6.9% in total fee revenue, but down 1.0% QoQ due to seasonal factors; net income attributable to U.S. Bancorp was $1,945 million, increasing 13.8% YoY while declining 4.9% QoQ. Average total loans grew 3.8% YoY and 2.4% QoQ to $393,560 million, and average total deposits rose 1.7% YoY but were flat QoQ at $515,119 million, though time deposits fell 16.0% YoY. The company announced partnerships with Amazon for new small business credit cards and with the NFL for banking, wealth management, and player financial programs.
- ·Diluted EPS of $1.18, up 14.6% YoY but down 6.3% QoQ
- ·Return on average assets 1.15%, improved YoY from 1.04%
- ·Efficiency ratio 58.2%, improved 260 bps YoY
- ·Net interest margin stable at 2.77% both YoY and QoQ
- ·CET1 capital ratio 10.8%
- ·Net charge-off ratio 0.56%
- ·Commercial loans up 11.4% YoY to $149,833 million
- ·Retail leasing down 11.7% YoY
- ·Noninterest-bearing deposits up 1.2% YoY but down 3.2% QoQ
16-04-2026
Versus Systems Inc. entered into a Stock Purchase Agreement with ASPIS Cyber Technologies, Inc. on April 15, 2026, under which it will sell common stock for total cash proceeds of $1,700,000 at a price equal to 105% of the closing price on the day preceding closing, expected on or before May 14, 2026. The Company anticipates these proceeds will enable it to maintain at least $2,500,000 in stockholders’ equity through December 31, 2026. No declines or flat metrics reported.
- ·Closing date selected by ASPIS on or before May 14, 2026.
- ·Agreement governed by laws of the State of New York.
16-04-2026
Vipshop Holdings Ltd's consolidated net revenues declined 2.3% YoY to RMB 105,919,546 thousand for the year ended December 31, 2025, from RMB 108,420,832 thousand in 2024, continuing a downward trend with a 3.9% drop from RMB 112,856,020 thousand in 2023. Net income fell 5.5% to RMB 7,409,639 thousand in 2025 from RMB 7,838,945 thousand in 2024, after a 4.4% decrease from RMB 8,201,299 thousand in 2023. Comprehensive income also declined to RMB 7,392,707 thousand in 2025 from RMB 7,727,140 thousand in 2024.
- ·Vipshop China, Chongqing Pinwei, and their subsidiaries accounted for 90%, 90%, and 89% of total net revenue in 2023, 2024, and 2025, respectively.
- ·Vipshop China, Chongqing Pinwei, and their subsidiaries accounted for 97%, 98%, and 94% of total net income in 2023, 2024, and 2025, respectively.
- ·Eliminations primarily represent intercompany service fees for technology and marketing services.
- ·Vipshop E-Commerce (VIE): e-commerce platform; shareholders Eric Ya Shen (66.7%), Chan Huang (33.3%).
- ·Vipshop Information (VIE): finance services (nominal); shareholders Eric Ya Shen (99.2%), Chan Huang (0.8%).
- ·Pin Jun Tong (VIE): no substantive business; shareholders Eric Ya Shen (65%), Arthur Xiaobo Hong (35%).
16-04-2026
SHF Holdings, Inc. reported Q4 and FY 2025 results showing a major balance sheet transformation, eliminating substantially all $18M debt, ending with $6.8M cash (up from $2.3M YoY) and $8.2M positive stockholders' equity (vs -$12.3M prior year). Q4 revenue increased 12% sequentially to $2.1M with 70% QoQ growth in loan program income due to updated PCCU agreement, but declined 44% YoY; full-year revenue fell to $7.7M from $15.2M amid a $2.2M net loss (improved from $48.3M prior year). Operating expenses dropped 72% YoY in Q4 but rose 8% QoQ, reflecting ongoing operational leverage amid mixed performance.
- ·PCCU agreement extended through 2031 with loan program income share up to 65% (from 35%) and 23% reduction in asset hosting fee.
- ·Q4 Adjusted EBITDA ($1.1M) vs Q4 2024 ($0.1M); FY 2025 Adjusted EBITDA ($3.9M loss) vs FY 2024 ($2.9M).
- ·FY 2025 loan program income $2.5M vs $6.6M in FY 2024.
16-04-2026
BNY reported record Q1 2026 total revenue of $5.4 billion, up 13% YoY and 4% QoQ, driven by 11% YoY fee revenue growth and 18% YoY net interest income increase, with diluted EPS rising 42% YoY to $2.24 and ROTCE at 29%. However, AUM declined 2% QoQ to $2.1 trillion amid net outflows, Investment and Wealth Management segment revenue fell 3% QoQ, and Issuer Services revenue dropped 16% QoQ. Noninterest expense rose 5% YoY to $3.4 billion, though pre-tax operating margin expanded to 37%.
- ·Average liquidity coverage ratio (LCR) of 111%; Average net stable funding ratio (NSFR) of 131%.
- ·Tier 1 leverage ratio of 6.0%; CET1 ratio of 11.0%.
- ·Securities Services AUC/A of $42.7T (flat QoQ, up 13% YoY).
- ·Market and Wealth Services AUC/A of $16.5T (up 2% QoQ, 11% YoY).
- ·Provision for credit losses benefit of $7M in Q1 2026.
16-04-2026
MeiraGTx Holdings plc announced positive 3-year data from its Phase 1 AQUAx clinical study of AAV-hAQP1 for grade 2/3 radiation-induced xerostomia, demonstrating maintained Xerostomia Questionnaire (XQ) improvements with 62% of participants achieving at least a 10-point improvement and an average 17-point improvement from baseline through Month 36. Unstimulated Whole Saliva Flow Rate (UWSFR) normalized to 0.34 mL/min at Month 36, within the normal range, with the treatment safe and well-tolerated across doses and no treatment-related serious adverse events. The company estimates peak global annual revenue potential of $3.7 billion and U.S. peak of $2.0 billion for this potential first-in-class therapy, targeting 165,000 U.S. patients with persistent RIX.
- ·Unilateral participants: average 13-point XQ improvement at Month 12, maintained through Month 36.
- ·Bilateral participants: average 21-point XQ improvement at Month 12, maintained through Month 36.
- ·No dose-limiting toxicity or treatment-related serious adverse events observed.
16-04-2026
Korro Bio, Inc. (KRRO) filed a Definitive Additional Proxy Statement (DEFA14A) on April 16, 2026, for its Annual Meeting of Stockholders scheduled for June 11, 2025, at 11:00 AM ET via the Internet. Key proposals include the election of three Class III directors (Ram Aiyar, Jean-Francois Formela, Katharine Knobil) for three-year terms expiring in 2028, a non-binding advisory vote on named executive officer compensation, a non-binding advisory vote on the frequency of future say-on-pay votes (board recommends one year), and ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2025. Stockholders of record as of April 15, 2025, must access full proxy materials online at www.proxydocs.com/KRRO to vote.
- ·Board recommends: FOR nominees in Proposal 1, FOR frequency of one year in Proposal 3, FOR Proposals 2 and 4.
- ·Registration deadline to attend/participate online: 5:00 PM ET on June 10, 2025.
- ·Proxy materials available at www.proxydocs.com/KRRO; paper copies via www.investorelections.com/KRRO or 1-866-648-8133.
16-04-2026
Korro Bio, Inc. (KRRO) filed its DEF 14A definitive proxy statement on April 16, 2026, for the virtual 2026 Annual Meeting of Stockholders on June 10, 2026, at 8:30 a.m. ET, with a record date of April 13, 2026. Proposals include election of Class I directors Nessan Bermingham and Rachel Meyers for three-year terms, a non-binding advisory vote to approve named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing.
- ·Virtual meeting registration deadline: June 9, 2026, at 5:00 p.m. ET at www.proxydocs.com/KRRO.
- ·Notice of Availability mailed on or about April 20, 2026.
- ·Company address: 60 First Street, 2nd Floor, Suite 250, Cambridge, MA 02141.
- ·References 2025 Annual Report (Form 10-K for fiscal year ended December 31, 2025) available online.
16-04-2026
Travelers Companies, Inc. reported Q1 2026 total revenues of $11,924 million, up 1% YoY from $11,810 million, with net investment income rising 8% to $1,008 million, but premiums slightly down 1% to $10,605 million and Personal Insurance premiums declining 4% YoY to $4,094 million. Net income surged 333% to $1,711 million from $395 million, primarily due to claims and claim adjustment expenses dropping 20% to $6,382 million. Comprehensive income increased to $1,133 million from $794 million despite a net OCI loss of $578 million.
- ·Proceeds from divestiture of Canadian business: $2,384 million in Q1 2026.
- ·Net cash provided by operating activities: $2,198 million in Q1 2026 (up from $1,360 million YoY).
- ·Treasury stock acquired under repurchase authorizations: $1,800 million and 6.0 million shares in Q1 2026.
- ·Total shareholders’ equity: $31,986 million as of March 31, 2026 (down from $32,894 million at Dec 31, 2025).
- ·Cash dividends declared per common share: $1.10 in Q1 2026 (up from $1.05).
16-04-2026
MeiraGTx Holdings plc entered into an asset purchase agreement with Johnson & Johnson to acquire botaretigene sparoparvovec (bota-vec) for X-linked Retinitis Pigmentosa (XLRP) for a $25 million upfront cash payment, plus milestones and high double-digit royalties, intending to file for regulatory approval in the US, EU, and Japan aiming for a 2027 launch. Phase 3 LUMEOS data showed strong secondary endpoints with statistically significant improvements in visual function, retinal sensitivity, and 40% of treated patients as multi-endpoint responders, including 45% gaining >10 letters in low luminance visual acuity; however, the primary Visual Mobility Assessment endpoint did not meet statistical significance despite being directionally supportive (2.4x more likely to respond). The acquisition leverages MeiraGTx's manufacturing capabilities and relationships with key opinion leaders at 32 of 40-50 centers of excellence.
- ·Primary endpoint (VMA) did not meet statistical significance but directionally supportive (treated subjects 2.4x more likely to respond).
- ·LLQ PRO significant benefit in mobility and dim light function (p=0.006 extreme lighting, p=0.001 mobility, p=0.007 general dim lighting).
- ·IVI-A significant improvement total score (p=0.024), emotional wellbeing (p=0.005).
- ·Retinal sensitivity: pointwise responders central 30° (p=0.001), full field (p=0.001); mean sensitivity central 10° (p=0.001), full field 90° (p=0.004).
- ·LLVA change LS mean (p=0.003).
- ·Safety profile manageable, no new signals, improved inflammatory profile vs Phase 1/2.
- ·FDA Fast Track and Orphan Drug Designations; EU PRIME, ATMP, Orphan Drug Designations.
- ·MeiraGTx has commercial licenses for manufacturing in London and QC in Shannon, Ireland; several hundred vials ready.
16-04-2026
BlueSky Wealth Advisors, LLC filed its 13F-HR report disclosing $776.5 billion in equity holdings as of March 31, 2026, across 115 positions held on a sole discretionary basis. The portfolio is dominated by ETFs such as the Schwab Strategic TR US LRG CAP ETF ($125.3B) and Vanguard Scottsdale FDS Inter Term Treas ($46.5B), alongside individual stocks like NVIDIA ($13.0B). No prior period comparisons or changes are provided in the filing.
- ·Report period end date: March 31, 2026
- ·Filing date: April 16, 2026
- ·All positions held as sole discretionary power
- ·Investment advisor CIK: 0001704107, based in New Bern, NC
16-04-2026
Soluna Holdings, Inc. announced the acquisition of Spring Lane Capital’s equity interest in Project Dorothy 1A for $16.5 million on April 16, 2026. The company issued a press release (Exhibit 99.1) and made an investor presentation (Exhibit 99.2) available on its investor relations website. No financial performance metrics, period comparisons, or negative developments were disclosed in the filing.
Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings
More from: Dow Jones 30 Stocks SEC Filings
🇺🇸 More from United States
View all →April 09, 2026
US Pre-Market SEC Filings Roundup — April 09, 2026
US Pre-Market SEC Filings Roundup
April 09, 2026
US Merger & Acquisition SEC Filings — April 09, 2026
US Merger & Acquisition SEC Filings
April 09, 2026
US Corporate Board Director Changes SEC Filings — April 09, 2026
US Corporate Board Director Changes SEC Filings
April 09, 2026
US Executive Officer Management Changes SEC — April 09, 2026
US Executive Officer Management Changes SEC